1. Home
  2. PHAR vs TRTX Comparison

PHAR vs TRTX Comparison

Compare PHAR & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • TRTX
  • Stock Information
  • Founded
  • PHAR 1988
  • TRTX 2014
  • Country
  • PHAR Netherlands
  • TRTX United States
  • Employees
  • PHAR N/A
  • TRTX N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • TRTX Real Estate Investment Trusts
  • Sector
  • PHAR Health Care
  • TRTX Real Estate
  • Exchange
  • PHAR Nasdaq
  • TRTX Nasdaq
  • Market Cap
  • PHAR 624.1M
  • TRTX 718.6M
  • IPO Year
  • PHAR N/A
  • TRTX 2017
  • Fundamental
  • Price
  • PHAR $8.86
  • TRTX $8.32
  • Analyst Decision
  • PHAR Strong Buy
  • TRTX Buy
  • Analyst Count
  • PHAR 3
  • TRTX 6
  • Target Price
  • PHAR $27.00
  • TRTX $8.92
  • AVG Volume (30 Days)
  • PHAR 5.9K
  • TRTX 491.2K
  • Earning Date
  • PHAR 03-13-2025
  • TRTX 02-18-2025
  • Dividend Yield
  • PHAR N/A
  • TRTX 11.54%
  • EPS Growth
  • PHAR N/A
  • TRTX N/A
  • EPS
  • PHAR N/A
  • TRTX 0.75
  • Revenue
  • PHAR $285,745,000.00
  • TRTX $148,968,000.00
  • Revenue This Year
  • PHAR $20.08
  • TRTX N/A
  • Revenue Next Year
  • PHAR $9.22
  • TRTX $3.60
  • P/E Ratio
  • PHAR N/A
  • TRTX $11.13
  • Revenue Growth
  • PHAR 30.64
  • TRTX N/A
  • 52 Week Low
  • PHAR $6.65
  • TRTX $6.74
  • 52 Week High
  • PHAR $12.20
  • TRTX $9.66
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 48.50
  • TRTX 42.45
  • Support Level
  • PHAR $8.50
  • TRTX $7.98
  • Resistance Level
  • PHAR $9.50
  • TRTX $8.75
  • Average True Range (ATR)
  • PHAR 0.56
  • TRTX 0.19
  • MACD
  • PHAR 0.03
  • TRTX -0.02
  • Stochastic Oscillator
  • PHAR 58.71
  • TRTX 43.51

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.

Share on Social Networks: